McDonald Kathleen, Trick Leanne, Boyle Julia
Surrey Clinical Research Centre, University of Surrey, Egerton Road, Guildford, Surrey, UK.
Hum Psychopharmacol. 2008 Oct;23(7):555-70. doi: 10.1002/hup.962.
The use of antihistamines (AHs) has been associated with cognitive and psychomotor impairments, largely caused by the sedative properties of many of these drugs. Due to the ambulant nature of the population using AHs, it is important to evaluate these effects using standardised methodology and psychometric tests. A previous extensive review of the literature collated the results of studies of H(1) receptor antagonists to determine the extent to which a particular AH produced impairments on a battery of psychometric tests by calculating a proportional impairment ratio for each AH.
In light of a number of major studies published following the previous review, and the development of the second and new-generation AHs, the present review aims to add to the database and update the review, using the same methodology.
The newer generation AHs appear to be the least impairing, and the first generation, as expected, appear to be the most impairing. There are also differences within the AH drug generations. The review highlights the necessity to consider the sedating potential of AHs, along with other factors such as efficacy, when prescribing AHs to ambulant patients.
使用抗组胺药(AHs)与认知和精神运动功能损害有关,这在很大程度上是由许多此类药物的镇静特性所致。鉴于使用AHs的人群具有流动性,采用标准化方法和心理测量测试来评估这些影响很重要。先前一项广泛的文献综述整理了H(1)受体拮抗剂的研究结果,通过计算每种AH的比例损害率来确定特定AH在一系列心理测量测试中产生损害的程度。
鉴于先前综述之后发表的一些主要研究以及第二代和新一代AHs的研发,本综述旨在使用相同方法补充数据库并更新该综述。
新一代AHs似乎造成的损害最小,而第一代AHs正如预期的那样,造成的损害最大。在AH药物代内也存在差异。该综述强调,在为流动患者开具AHs处方时,有必要考虑AHs的镇静潜力以及其他因素,如疗效。